Tobacco firm Reynolds 'stubs out $47bn BAT offer' Published US cigarette maker Reynolds American has rejected a buyout offer worth $47bn (38bn) from British American Tobacco, according to reports
Nicotine Replacement Therapy (NRT): Nicotine replacement therapy, available in forms like patches, gums, lozenges, inhalers, and nasal sprays, can help smokers quit by providing controlled doses of nicotine to alleviate withdrawal symptoms
Since e-cigarettes produce much less tar, carbon monoxide, and carcinogenic ingredients such as aldehydes, acids, and phenols, the exclusive use of e-cigarettes among smokers may reduce the number of diseases caused by such ingredients [14,15,16]
From a flavor ban to the FDA's decisions on PMTAs and cigarette warning label mandates, CSP spoke to industry watchers about what the top regulation concerns are for tobacco retailers